The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Risedronate Sodium
Risedronate Sodium · RISEDRONATE SODIUM 35 mg/1 · Tablet, Film Coated · Oral · Proficient Rx LP
NDC 71205-0714-04 · 1 BLISTER PACK in 1 CARTON / 4 TABLET, FILM COATED in 1 BLISTER PACK · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 33342-0109-37) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$2.82per unit
middle half $2.38–$5.14 · 4,797 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $2.82
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
87%of plans cover it
tier 3 · prior auth 0% · step therapy 0% · qty limit 80%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for risedronate sodium (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Proficient Rx LPUnited Statesrelabel
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA090877
- TE code
- AB
- Approval date
- Jun 10, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Risedronate Sodium (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Allergan, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | RISEDRONATE SODIUM 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | RISEDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | RISEDRONATE SODIUM 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | RISEDRONATE SODIUM 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 30.1 mg/1; RISEDRONATE SODIUM MONOHYDRATE 4.9 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals, Inc. | RISEDRONATE SODIUM HEMIPENTAHYDRATE 129 mg/1; RISEDRONATE SODIUM MONOHYDRATE 21 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Pel Healthcare Llc | RISEDRONATE SODIUM MONOHYDRATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | RISEDRONATE SODIUM 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE 75 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | RISEDRONATE SODIUM MONOHYDRATE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | RISEDRONATE SODIUM MONOHYDRATE 35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | RISEDRONATE SODIUM MONOHYDRATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | RISEDRONATE SODIUM 30 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Risedronate Sodium — NDC 71205-0714-04," retrieved September 3, 2026, https://drugdashboards.com/drug/71205071404.
Free to cite with attribution — see how the data is put together.